Extrathoracic investigation in adult patients with isolated pulmonary langerhans cell histiocytosis

被引:10
|
作者
Tazi, Abdellatif [1 ,2 ]
de Margerie-Mellon, Constance [3 ]
Vercellino, Laetitia [4 ]
Naccache, Jean Marc [5 ]
Fry, Stephanie [6 ]
Dominique, Stephane [7 ]
Jouneau, Stephane [8 ]
Lorillon, Gwenael [1 ]
Bugnet, Emmanuelle [1 ]
Chiron, Raphael [9 ]
Wallaert, Benoit [6 ,10 ]
Valeyre, Dominique [11 ]
Chevret, Sylvie [2 ,12 ]
机构
[1] Hop St Louis, AP HP, Ctr Natl Reference Histiocytose Langerhansienne, Serv Pneumol, 1 Ave Claude Vellefaux, F-75475 Paris 10, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, Biostat & Clin Epidemiol Res Team, CRESS U1153, Paris, France
[3] Hop St Louis, AP HP, Serv Radiol, F-75475 Paris 10, France
[4] Hop St Louis, AP HP, Nucl Med Serv, F-75475 Paris 10, France
[5] Hop Avicenne, AP HP, Serv Pneumol, F-93009 Bobigny, France
[6] Hop A Calmette, Ctr Competence Malad Pulm Rares, Serv Pneumol & Immuno Allergol, F-59037 Lille, France
[7] Hop Charles Nicolle, Dept Pneumol, Rouen, France
[8] Univ Rennes 1, Hop Pontchaillou, Serv Pneumol, IRSET UMR 1085, Rennes, France
[9] Hop Arnaud Villeneuve, Dept Pneumol, Montpellier, France
[10] Univ Lille 2, Lille, France
[11] Univ Paris 13, Hop Avicenne, AP HP, Sorbonne Paris Cite,Serv Pneumol, Bobigny, France
[12] Hop St Louis, AP HP, Serv Biostat & Informat Med, F-75475 Paris 10, France
来源
关键词
Langerhans cell histiocytosis; Bone x-ray; Bone scan; Blood cell count; Liver biology; Management; CLADRIBINE; MANAGEMENT; LUNG; FEATURES; SOCIETY; LIVER;
D O I
10.1186/s13023-016-0387-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: An important objective on diagnosis of patients with Langerhans cell histiocytosis (LCH) is to determine the extent of disease. However, whether systematic extrathoracic investigation is needed in adult patients with clinically isolated pulmonary LCH (PLCH) has not been evaluated. Methods: In this prospective, multicentre study, 54 consecutive patients with newly diagnosed clinically isolated PLCH were systematically evaluated at inclusion by bone imaging and blood laboratory testing to search for subclinical extrapulmonary LCH involvement. The patients were followed over a 2-year period. At each visit, they were asked about the presence of extrapulmonary manifestations of LCH. Results: In the absence of bone symptoms, the skeletal X-ray survey results were normal for all but two patients who had a localised bone lesion consistent with possible LCH involvement, that remained unchanged over 2 years of follow-up. Whole-body bone scintigraphy did not add information to the plain radiography findings for the detection of asymptomatic bone involvement in isolated PLCH. Conversely, it showed nonspecific focal bone uptake in 18 % of the patients, mainly corresponding to post-traumatic or degenerative abnormalities unrelated to LCH. Mild leucocytosis due to neutrophilia was observed in 22 % of the patients and was not related to their smoking habits. Three patients had mild isolated lymphocytosis without haematological disease, whereas two patients had mild lymphopaenia. A mild inflammatory biological syndrome was observed in a minority of patients without infection or constitutional symptoms and was not associated with progressive disease. A substantial proportion (24.5 %) of the patients had abnormal biological liver test results, including elevated liver enzymes and/or cholestasis, which were not linked to LCH involvement in this cohort. Conclusions: Obtaining a thorough history and performing comprehensive physical examination are essential for staging patients diagnosed with PLCH. In the absence of symptoms or signs suggestive of extrapulmonary LCH involvement, the systematic performing of recommended bone imaging does not appear informative. Although the observed blood laboratory abnormalities were not specifically related to LCH, performing these tests in the diagnostic workup for PLCH is useful because some of these alterations may impact patient management.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Pulmonary Langerhans' cell histiocytosis
    Koschel, D
    Müller-Wening, D
    MEDIZINISCHE KLINIK, 2003, 98 (08) : 461 - 463
  • [42] Pulmonary Langerhans Cell Histiocytosis
    Lin, Mong-Wei
    Chang, Yih-Leong
    Lee, Yung-Chie
    Cheng, Hsiu-Ling
    Chen, Jing-Shen
    Hsu, Hsao-Hsun
    LUNG, 2009, 187 (04) : 261 - 262
  • [43] Pulmonary Langerhans cell histiocytosis
    Kose, Mehmet
    Ozdemir, Mehmet Akif
    EUROPEAN JOURNAL OF PEDIATRICS, 2013, 172 (09) : 1283 - 1283
  • [44] Pulmonary Langerhans'-cell histiocytosis
    Miller, WT
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (22): : 1656 - 1656
  • [45] Pulmonary Langerhans' cell histiocytosis
    Barcat, D
    Constans, I
    Laurent, F
    de Lara, MT
    Conri, C
    REVUE DE MEDECINE INTERNE, 2003, 24 : 270S - 271S
  • [46] Pulmonary Langerhans' cell histiocytosis
    Vassallo, R
    Limper, AH
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 23 (02) : 93 - 101
  • [47] Pulmonary Langerhans Cell Histiocytosis
    Mong-Wei Lin
    Yih-Leong Chang
    Yung-Chie Lee
    Hsiu-Ling Cheng
    Jing-Shen Chen
    Hsao-Hsun Hsu
    Lung, 2009, 187 : 261 - 262
  • [48] Pulmonary Langerhans' Cell Histiocytosis
    Chaulagain, Chakra P.
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (11): : E5 - E6
  • [49] Pulmonary langerhans cell histiocytosis
    Harpreet S Suri
    Eunhee S Yi
    Gregorz S Nowakowski
    Robert Vassallo
    Orphanet Journal of Rare Diseases, 7
  • [50] Pulmonary Langerhans Cell Histiocytosis
    Kooblall, M.
    Lane, S.
    Moloney, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189